DR-70^(TM)的检测在肿瘤诊断中的价值探讨  

The Value of Using DR 70 TM for Cancer Detection in Tumor Diagnosis

作　　者：吴东方[1] 周新 许志金[1] 李瑞炎 夏琳 余晓萍 谢文 柴红艳 

机构地区：[1]湖北省肿瘤医院

出　　处：《湖北医科大学学报》1999年第3期194-196,共3页

摘　　要：采用美国生产肿瘤标志物（ＤＲ７０ＴＭ）试剂以免疫学酶联方法对１４种癌症３５０例患者和３３５例健康人进行对照检测，其结果表明：肺癌阳性率约为８８１％；胃癌为９２８５％；乳腺癌为６５６７％；肠癌为８３３３％；肝癌为９１８９％；卵巢癌为９３７５％；食道癌为９２８５％和宫颈癌为８７５０％等，总计癌症患者阳性率约为８２２８％，与健康对照组比较，Ｐ＜０００１，差异有高度显著性。认为ＤＲ７０ＴＭ试剂可作为辅助诊断及监测肿瘤复发的指标，为临床提供参考依据。A clinical study using DR 70 TM immunoassay for the detection of 14 different kinds of cancer was conducted with 335 healthy subjects and 350 cancer patients.The test results showed that the DR 70 TM immunoassay kit was capable of detecting cancers with high degree of specificity and sensitivity,at 88.1%,92.85%,65.67%,83.33%,91.89%,93.75%,92.83%and 87.50% respectively for lung,stomach,breast,rectum,liver,ovary,esophagus and cervix.Furthermore,the test kit was shown to be stable and could be performed reproducibly.

关 键 词：肿瘤 诊断 肿瘤标记物 DR-70^TM 

分 类 号：R730.43[医药卫生—肿瘤]